JP2021528407A5 - - Google Patents
Info
- Publication number
- JP2021528407A5 JP2021528407A5 JP2020570467A JP2020570467A JP2021528407A5 JP 2021528407 A5 JP2021528407 A5 JP 2021528407A5 JP 2020570467 A JP2020570467 A JP 2020570467A JP 2020570467 A JP2020570467 A JP 2020570467A JP 2021528407 A5 JP2021528407 A5 JP 2021528407A5
- Authority
- JP
- Japan
- Prior art keywords
- transgene
- therapeutic agent
- combination therapeutic
- based vector
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810301.0A GB201810301D0 (en) | 2018-06-22 | 2018-06-22 | Combinatorial gene therapy |
| GB1810301.0 | 2018-06-22 | ||
| PCT/EP2019/066471 WO2019243574A1 (en) | 2018-06-22 | 2019-06-21 | Combinatorial gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021528407A JP2021528407A (ja) | 2021-10-21 |
| JP2021528407A5 true JP2021528407A5 (https=) | 2022-06-24 |
Family
ID=63042788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570467A Pending JP2021528407A (ja) | 2018-06-22 | 2019-06-21 | 組合せ遺伝子治療薬 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210252164A1 (https=) |
| EP (1) | EP3810206B1 (https=) |
| JP (1) | JP2021528407A (https=) |
| KR (1) | KR20210024040A (https=) |
| CN (1) | CN112955185A (https=) |
| AU (1) | AU2019289998A1 (https=) |
| BR (1) | BR112020026260A2 (https=) |
| CA (1) | CA3104432A1 (https=) |
| GB (1) | GB201810301D0 (https=) |
| IL (1) | IL279584A (https=) |
| MX (1) | MX2020013865A (https=) |
| SG (1) | SG11202012727SA (https=) |
| WO (1) | WO2019243574A1 (https=) |
| ZA (1) | ZA202100244B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022315530A1 (en) | 2021-07-20 | 2024-01-18 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their preparation, and uses |
| WO2023144127A1 (en) | 2022-01-31 | 2023-08-03 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their biodistribution upon administration, and uses |
| WO2023232976A1 (en) | 2022-06-03 | 2023-12-07 | Ags Therapeutics Sas | Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses |
| WO2024088808A1 (en) | 2022-10-24 | 2024-05-02 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their biodistribution upon intranasal administration, and uses thereof |
| WO2025176843A1 (en) | 2024-02-21 | 2025-08-28 | Ags Therapeutics Sas | Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001273150A1 (en) * | 2000-07-20 | 2002-02-05 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| CN102813942A (zh) * | 2012-08-15 | 2012-12-12 | 钟志容 | 脂质超声微泡介导的腺相关病毒基因转染制剂及制备工艺 |
| WO2015002956A1 (en) * | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Exosome delivery system |
| EP3842537A1 (en) * | 2013-12-30 | 2021-06-30 | CureVac AG | Artificial nucleic acid molecules |
| CA2960164A1 (en) * | 2014-09-05 | 2016-03-10 | Exerkine Corporation | Methods of producing and using exersomes and bioengineered exersomes |
| WO2016044947A1 (en) * | 2014-09-26 | 2016-03-31 | Exerkine Corporation | Exosomes useful to treat lysosomal storage disease |
| AU2017241534A1 (en) * | 2016-03-28 | 2018-10-04 | The Regents Of The University Of California | Method and composition for treating neuronal hyper-excitability |
| GB2568255A (en) * | 2017-11-08 | 2019-05-15 | Evox Therapeutics Ltd | Exosomes comprising RNA therapeutics |
-
2018
- 2018-06-22 GB GBGB1810301.0A patent/GB201810301D0/en not_active Ceased
-
2019
- 2019-06-21 SG SG11202012727SA patent/SG11202012727SA/en unknown
- 2019-06-21 MX MX2020013865A patent/MX2020013865A/es unknown
- 2019-06-21 AU AU2019289998A patent/AU2019289998A1/en not_active Abandoned
- 2019-06-21 CN CN201980042058.3A patent/CN112955185A/zh active Pending
- 2019-06-21 JP JP2020570467A patent/JP2021528407A/ja active Pending
- 2019-06-21 BR BR112020026260-9A patent/BR112020026260A2/pt not_active IP Right Cessation
- 2019-06-21 WO PCT/EP2019/066471 patent/WO2019243574A1/en not_active Ceased
- 2019-06-21 EP EP19732641.6A patent/EP3810206B1/en active Active
- 2019-06-21 US US17/252,335 patent/US20210252164A1/en not_active Abandoned
- 2019-06-21 CA CA3104432A patent/CA3104432A1/en active Pending
- 2019-06-21 KR KR1020217001827A patent/KR20210024040A/ko not_active Withdrawn
-
2020
- 2020-12-20 IL IL279584A patent/IL279584A/en unknown
-
2021
- 2021-01-13 ZA ZA2021/00244A patent/ZA202100244B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021528407A5 (https=) | ||
| Lundstrom | Viral vectors in gene therapy: where do we stand in 2023? | |
| Zhao et al. | Viral vector‐based gene therapies in the clinic | |
| US10149914B2 (en) | Liver-specific nucleic acid regulatory elements and methods and use thereof | |
| JP2008545406A5 (https=) | ||
| JP2008056679A5 (https=) | ||
| Wang et al. | Potential cancer gene therapy by baculoviral transduction | |
| Aurélie et al. | Lentiviral vectors: a powerful tool to target astrocytes in vivo | |
| JP2019523648A5 (https=) | ||
| JP2018533949A5 (https=) | ||
| JP2019524090A5 (https=) | ||
| JP2021533801A5 (https=) | ||
| JP2011115077A5 (https=) | ||
| Serguera et al. | Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain | |
| US20070020237A1 (en) | Glucose inducible insulin expression and methods of treating diabetes | |
| JP2024511808A (ja) | ウイルスベクターに基づくｒｎａ送達システム及びその使用 | |
| RU2021101174A (ru) | Комбинаторная генная терапия | |
| Rasoul et al. | Use of viral vector to deliver IL-15 for cancer therapy: An overview | |
| Herzog et al. | A guide to human gene therapy | |
| Yu et al. | Nucleic acid-encoded antibody gene transfer-next generation of antibody therapies | |
| CN118634243B (zh) | Mir2911在制备抗登革病毒denv的药物中的应用 | |
| Lundstrom | RNA Viruses and Gene Therapy | |
| WO2026081151A1 (zh) | 一种CRISPR介导的基因转录激活（CRISPRa）系统及其应用 | |
| Rusconi et al. | Vectors for gene delivery | |
| WO2024234966A1 (zh) | 耳蜗内毛细胞特异性启动子及其应用 |